MGLU2 AGONISTS

The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.

Saved in:
Bibliographic Details
Main Authors CARLOS MONTERO SALGADO, JAMES ALLEN MONN, LORENA TABOADA MARTINEZ, BRUCE WILLIAM SHAW, LOURDES PRIETO
Format Patent
LanguageEnglish
Portuguese
Published 10.10.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.
Bibliography:Application Number: PT20100798419T